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1. INTRODUCTION {#pld347-sec-0001}
===============

Viral resistance in plants is mediated by multiple mechanisms consisting of effector‐triggered immunity (ETI), loss or mutation of host genes essential for viral infection (Kang, Yeam, & Jahn, [2005](#pld347-bib-0016){ref-type="ref"}; Maule, Caranta, & Boulton, [2007](#pld347-bib-0020){ref-type="ref"}; Wang & Krishnaswamy, [2012](#pld347-bib-0029){ref-type="ref"}), and RNA interference (RNAi)‐based innate immunity targeting viral RNAs (Ding, [2010](#pld347-bib-0010){ref-type="ref"}), among others. ETI is conferred through the recognition of viral encoded elicitors by dominant *R* gene products (Kang et al., [2005](#pld347-bib-0016){ref-type="ref"}; Maule et al., [2007](#pld347-bib-0020){ref-type="ref"}; Wang & Krishnaswamy, [2012](#pld347-bib-0029){ref-type="ref"}). The best‐studied ETI‐based viral resistance is *N* gene‐mediated resistance to tobacco mosaic virus. *N* gene encodes a protein with typical R protein features: a Toll, interleukin‐1‐related region (TIR), a nucleotide‐binding site (NBS) domain, and a leucine‐rich repeat (LRR) domain. The *N* gene product recognizes the helicase‐domain of the replication protein to trigger the hypersensitive response (Erickson et al., [1999](#pld347-bib-0011){ref-type="ref"}; Padgett, Watanabe, & Beachy, [1997](#pld347-bib-0022){ref-type="ref"}). Among 14 identified recessive *R* genes, 12 encode mutants of either eukaryotic initiation factor 4E (eIF4E) or its isoform eIF(iso)4E (Wang & Krishnaswamy, [2012](#pld347-bib-0029){ref-type="ref"}). Both eIF4E and eIF(iso)4E are involved in translation and function redundantly in plant growth and development. However, one of them but not both is required for infection of some viruses (Wang & Krishnaswamy, [2012](#pld347-bib-0029){ref-type="ref"}). At least for potyviruses, a physical interaction between wild‐type (wt) eIF(iso)4E or eIF4E and a specific viral protein, termed viral protein genome‐linked (VPg), has been demonstrated. Resistance gene‐encoded eIF4E or eIF(iso)4E mutants fail to interact with VPg and conversely, resistance‐breaking potyvirus isolates bear mutations in VPg (Wang & Krishnaswamy, [2012](#pld347-bib-0029){ref-type="ref"}). In crop plants, ETI may be highly specific to certain strains or may not be durable due to viral mutation in R‐protein recognized elicitors. Recessive resistance genes are durable; however, not many are available. In addition, viral genomes often encode suppressors of host RNAi machinery (termed viral suppressors of RNA silencing) rendering RNAi‐based resistance ineffective (Anandalakshmi et al., [1998](#pld347-bib-0003){ref-type="ref"}; Incarbone & Dunoyer, [2013](#pld347-bib-0013){ref-type="ref"}; Kasschau & Carrington, [1998](#pld347-bib-0017){ref-type="ref"}) and in many cases, allowing the coinfecting viruses to replicate to much higher levels that lead to detrimental diseases in host plants (Anandalakshmi et al., [1998](#pld347-bib-0003){ref-type="ref"}).

The CRISPR‐Cas (Clustered, regularly interspaced short palindromic repeats‐CRISPR‐associated) system is an adaptive immune defense mechanism employed by bacteria and archaea to fight against invading viruses and foreign nucleic acid materials (Makarova et al., [2011](#pld347-bib-0019){ref-type="ref"}; Sander & Joung, [2014](#pld347-bib-0026){ref-type="ref"}). The engineered CRISPR‐Cas system includes a single‐guide RNA (sgRNA) and a Cas nuclease (Jinek et al., [2012](#pld347-bib-0015){ref-type="ref"}). The sgRNA, via the 20‐nucleotide spacer region, anneals to the complementary strand of the targeted double‐stranded DNA (dsDNA) and recruits the Cas nuclease to make dsDNA breaks at the target site. Mutational insertions and/or deletions are introduced when the breaks are joined and repaired incorrectly. The class II CRISPR‐Cas9 system has been engineered to confer resistance to various human viruses (Price, Grakoui, & Weiss, [2016](#pld347-bib-0024){ref-type="ref"}) and plant geminiviruses (Ali et al., [2015](#pld347-bib-0001){ref-type="ref"}; Baltes et al., [2015](#pld347-bib-0004){ref-type="ref"}; Chaparro‐Garcia, Kamoun, & Nekrasov, [2015](#pld347-bib-0006){ref-type="ref"}; Ji, Zhang, Zhang, Wang, & Gao, [2015](#pld347-bib-0014){ref-type="ref"}). In the majority of these cases, an individual sgRNA is used and expressed at high levels. It has been reported that HIV mutants with mutations at the sgRNA‐targeting sites escape the CRISPR‐Cas9‐mediated viral resistance, suggesting multiple sgRNAs could be a better choice for virus control because they are harder to overcome by viruses (Wang, Zhao, Berkhout, & Das, [2016b](#pld347-bib-0032){ref-type="ref"}; Wang, Pan, et al., [2016](#pld347-bib-0030){ref-type="ref"}). Given that sgRNAs are highly structured RNAs with portions of dsRNA, it is possible that sgRNAs can be targeted by cellular RNAi machinery in transgenic plants or animals and thus, the abundance of sgRNAs could be under the regulation of cellular RNAi. However, it is unknown whether small interfering RNAs (siRNA) are generated in eukaryotic cells expressing prokaryotic sgRNAs.

Cauliflower mosaic virus (CaMV) is a plant pararetrovirus and has a dsDNA genome with three breaks, which are repaired in the nucleus prior to transcription during viral infection. CaMV mainly infects plant species in the *Brassicaceae* family, including *Arabidopsis thaliana*, and several *Nicotiana* species (Cecchini et al., [1998](#pld347-bib-0005){ref-type="ref"}; Schoelz, Shepherd, & Daubert, [1986](#pld347-bib-0027){ref-type="ref"}). We report here that expressing multiple sgRNAs targeting the CaMV coat protein (CP) coding sequence confers resistance to the virus in Arabidopsis transgenic plants. We have identified various large deletions of *CP* fragments as early as 3 days postinfection (DPI). However, we also show that edited viruses can escape the infection sites to move systematically in some transgenic plants. We have also found that small RNAs ranging from 21 to 24 nucleotides (nt) are generated from sgRNAs. The majority of siRNAs are mapped to the 3' end of the sgRNA backbone region and very infrequently to the spacer region, which anneals to the CaMV *CP* coding sequence. Our data demonstrate that the CRISPR‐Cas9 system can be used for virus control against plant pararetroviruses.

2. EXPERIMENTAL PROCEDURE {#pld347-sec-0002}
=========================

2.1. Cas9 target site selection and vector creation {#pld347-sec-0003}
---------------------------------------------------

Target sites in the CaMV *CP* gene (strain w260) were selected using standard Cas9 bioinformatic criteria (Table [1](#pld347-tbl-0001){ref-type="table"}). Linear arrays of Arabidopsis *U6 promoter::sgRNA* units were designed and subsequently synthesized by GeneArt/LifeTechnologies. Arrays were synthesized in groups and combined by stacking using restriction enzyme cloning (Peterson et al., [2016](#pld347-bib-0023){ref-type="ref"}). The arrays were cloned into the *pCUT3* binary vector, as were control *GLV* arrays containing 14 unique sgRNAs (Peterson et al., [2016](#pld347-bib-0023){ref-type="ref"}). As a control, the *CP* sgRNA array was cloned into the parental *pCUT3* plasmid lacking *Cas9*.

###### 

Cas9 target sites selected in the CaMV *CP* gene

  sgRNA   Sequence (PAM is underlined in sgRNA)
  ------- ---------------------------------------
  1       GAATGGTCTTTGGTTGAGT[TGG]{.ul}
  2       CTGAAGACGAAAGCGATTC[AGG]{.ul}
  3       ACAGGACCATTAACCGGTTC[TGG]{.ul}
  4       TGATAATTTGCAGGTCGAAC[AGG]{.ul}
  5       AGATTCCCAAAGAAGAAGA[TGG]{.ul}
  6       GACAAAAGCAGACGTCCAT[AGG]{.ul}

John Wiley & Sons, Ltd

2.2. Plant growth and transgenic line selection {#pld347-sec-0004}
-----------------------------------------------

The constructs were transformed into an *Agrobacterium tumefaciens* recA‐strain via triparental mating. Wild‐type *A. thaliana* Col‐0 plants grown under constant light at 21°C were transformed via the floral dip method (Clough & Bent, [1998](#pld347-bib-0008){ref-type="ref"}). T~1~ seeds derived from the transformed plants were collected and transgenic seedlings were selected on B5 media containing 100 mg/L kanamycin. Kanamycin resistant seedlings were transferred to soil (Sunshine \#1), and grown under 21°C, 16‐hour light/8‐hour dark conditions. T1 plants of *CUT CP/No Cas9* (Figure [1](#pld347-fig-0001){ref-type="fig"}), T2 (Figure [S4](#pld347-sup-0001){ref-type="supplementary-material"}) and T3 (Figure [1](#pld347-fig-0001){ref-type="fig"}) plants of two *CUT CP* transgenic lines (*CUT CP*‐1 and ‐2) were used for CaMV infections.

![CRISPR‐Cas9‐based CaMV resistance. (a) Cas9 is required for CRISPR‐Cas9 system‐mediated resistance. From left to right in rows, WT,*CUT GLV*,*CUT CP/No Cas9, CUT CP‐1*,*CUT CP‐2*. Photograph was taken at 20 DPI. Numbers below summarize the number of plants without symptoms in all inoculated plants. (b) Quantification of CaMV levels during Cas9‐mediated resistance. The ratio of *CP* against an internal *AtACTIN2* standard was calculated to determine the relative accumulation of CaMV. Error bars correspond to means ± SD of two independent experiments with three replicates per sample.](PLD3-2-e00047-g001){#pld347-fig-0001}

2.3. Viral infection {#pld347-sec-0005}
--------------------

Viral particles were isolated as described in (Schoelz et al., [1986](#pld347-bib-0027){ref-type="ref"}) and infected into plants using mechanical inoculation. Two primary leaves were inoculated per plants and were marked. Newly emerged systemic leaves or inoculated leaves at the specified days postinfection were harvested for DNA extraction.

2.4. Analysis of CaMV DNA levels {#pld347-sec-0006}
--------------------------------

The presence of CaMV was determined by real‐time PCR or PCR (Figure [1](#pld347-fig-0001){ref-type="fig"} and Figure [S4](#pld347-sup-0001){ref-type="supplementary-material"}) from DNA isolated from systemic plant tissue in infected plants using primers specific to the CaMV *CP* or *RT* (reverse transcriptase, ORF V) coding sequences (Table [2](#pld347-tbl-0002){ref-type="table"}). As an amplification control, primers (VTXW934 & 935) for Arabidopsis *ACTIN2* gene were used for each DNA sample (Table [2](#pld347-tbl-0002){ref-type="table"}). DNA was extracted by grinding leaf tissues in buffer TNES (0.2 M Tris‐HCl \[pH 7.5\], 0.25 M NaCl, 0.025 M EDTA \[pH 8.0\], and 0.5% SDS), followed by phenol and chloroform extractions. To sequence the CaMV *CP* coding sequences, the PCR product was cloned to EcoRV‐digested pBluescript KS plasmid (Stratagene, Agilent). For real‐time PCR quantification (Figure [1](#pld347-fig-0001){ref-type="fig"}), the primer pair VTXW1306 & 1307 was used to detect the *ACTIN2* gene and the primer pair VTXW1308 & 1309 was used to detect CaMV *CP*. DNA amplification was performed in the presence of iTaq Universal SYBR Green superMix (Biorad) using Applied Biosystems 7500 real‐time PCR system. Amplification conditions were as follows: 95**°**C for 2 min; 40 cycles of 15 s at 95**°**C, and 60 s at 60 **°**C. Melting curve analysis was included to verify specificity of the amplification. Copy number of each gene was calculated according to standard curves, which were generated from a serial dilution of the plasmid *pJT‐ACT2* or *pKS‐CaMV CP*. The ratios of CaMV *CP* vs. *ACTIN2* were calculated to demonstrate the relative accumulation of CaMV viruses.

###### 

PCR primers for host *ACTIN2*, CaMV *CP* and *RT*

  Primer name   *Gene target*   Purpose   Primer sequence
  ------------- --------------- --------- -------------------------
  VTXW1021      *CaMV RT*       PCR       AAAGGGACCACATTCCATTCG
  VTXW1139      *CaMV RT*       PCR       GAGCTTCATTGTTTCGTAGAC
  VTXW1308      *CaMV CP*       qPCR      TATTGCCCAAAAGGCAAGAA
  VTXW1309      *CaMV CP*       qPCR      ATGAGCCTTCTCCGAGCTTT
  VTXW1137      *CaMV CP*       PCR       TACCCCAATTACGGAGTAGG
  VTXW1138      *CaMV CP*       PCR       GTCTACGAAACAATGAAGCTC
  VTXW934       *AtACTIN2*      PCR       TAAGGTCGTTGCACCACCTG
  VTXW935       *AtACTIN2*      PCR       TGAACGATTCCTGGACCTGC
  VTXW1306      *AtACTIN2*      qPCR      GGTAACATTGTGCTCAGTGGTGG
  VTXW1307      *AtACTIN2*      qPCR      AACGACCTTAATCTTCATGCTGC

John Wiley & Sons, Ltd

2.5. Small RNA library construction and analysis {#pld347-sec-0007}
------------------------------------------------

Total RNA was isolated from Arabidopsis leaf samples using PureLink Plant RNA Reagent (Ambion). Eight small RNA libraries were prepared using TruSeq Small RNA Library Preparation Kits (Illumina). Eight small RNA libraries were constructed and were sequenced using an Illumina HiSeq 2500 at the Delaware Biotechnology Institute. Adapters in the raw sequencing data were trimmed. Small RNA reads between 18 nt and 30 nt were retained and were normalized to 10 million for comparisons among the libraries. Small RNA reads were mapped to the CaMV DNA sequence and sgRNA sequences allowing zero mismatches using Bowtie (Langmead, Trapnell, Pop, & Salzberg, [2009](#pld347-bib-0018){ref-type="ref"}). Target prediction was performed for small RNAs derived from sgRNAs in CaMV‐infected samples against the CaMV DNA sequence using "psRNATarget" (Dai & Zhao, [2011](#pld347-bib-0009){ref-type="ref"}).

3. RESULTS AND DISCUSSION {#pld347-sec-0008}
=========================

To test the applicability of the CRISPR‐Cas9 system in achieving resistance to CaMV, we designed six individual sgRNAs that targeted distinct sites in the *CP* coding sequence (Figure [S1](#pld347-sup-0001){ref-type="supplementary-material"} and Table [1](#pld347-tbl-0001){ref-type="table"}) (Chapdelaine & Hohn, [1998](#pld347-bib-0007){ref-type="ref"}). Each sgRNA contained 20 nucleotides that are either identical or complementary to the *CP* sequence, followed by a protospacer adjacent motif (PAM) sequence (Figure [S1](#pld347-sup-0001){ref-type="supplementary-material"} and Table [1](#pld347-tbl-0001){ref-type="table"}). Each sgRNA was expressed from its own Pol III *U6* promoter (Nekrasov, Staskawicz, Weigel, Jones, & Kamoun, [2013](#pld347-bib-0021){ref-type="ref"}). The set of six sgRNAs was cloned as a linear array into the *pCUT3* binary vector to create the *pCUT CP* construct (Figure [S2](#pld347-sup-0001){ref-type="supplementary-material"} for the map and pCUT CP.txt for the sequence), in which the Arabidopsis *UBQ10* promoter is used to express *Cas9* (Peterson et al., [2016](#pld347-bib-0023){ref-type="ref"}). In addition, we made a *pCUT CP‐No Cas9* construct (Figure [S3](#pld347-sup-0001){ref-type="supplementary-material"} and pCUT CP No Cas9.txt), in which the *Cas9* coding sequence was removed from *pCUT CP*. This construct serves as a negative control to demonstrate that the presence of CaMV‐targeting sgRNAs alone is unable to affect CaMV infection. Each of the two constructs was transformed into wild‐type (wt) Arabidopsis Col‐0 ecotype plants to make *CUT CP* or *CUT CP/No Cas9* transgenic plants. It should be noted that the transgenic plants harboring the above constructs grew normally and were fully fertile, indicating that the *CP* sgRNAs or Cas9 and sgRNA combinations did not negatively impact plant growth. As a specificity control, we also included a transgenic line *CUT GLV* (Peterson et al., [2016](#pld347-bib-0023){ref-type="ref"}), which contains a 14 sgRNA unit array targeting seven members of the Arabidopsis *GOLVEN* (*GLV*) gene family (Fernandez, Hilson, & Beeckman, [2013](#pld347-bib-0012){ref-type="ref"}).

We infected transgenic and Col‐0 plants with partially purified CaMV virions by mechanical inoculation and monitored symptom progression in systemic leaves. In Col‐0, *CUT GLV*, and *CUT CP/No Cas9* plants, vein clearing and chlorosis symptoms appeared on the inoculated leaves around 10 DPI. By 14 DPI, chlorosis extended to the majority of emerging systemic leaves. By three weeks, infected plants were highly chlorotic and stunted in 19, 16, and 17 of 20 inoculated Col‐0, *CUT GLV*, and *CUT CP/No Cas9* plants, respectively (Figure [1](#pld347-fig-0001){ref-type="fig"}a). This indicated that neither Cas9 nor sgRNAs targeting nonviral genomes confer resistance. Conversely, when 20 plants of two transgenic lines, *CUT CP*‐1 and ‐2, were tested, 17 and 18 plants remained symptomless at 20 DPI (Figure [1](#pld347-fig-0001){ref-type="fig"}a). Similar results were obtained in repeated infection assays where 81% and 96% (*CUT CP*‐1 and ‐2, Figure [S4](#pld347-sup-0001){ref-type="supplementary-material"}a) plants remained symptomless. CaMV was readily detectable in systemic leaves from infected WT, *CUT GLV*, and *CUT CP/No Cas9* lines by real‐time PCR for the *CP* gene (Figure [1](#pld347-fig-0001){ref-type="fig"}b) or by PCR for viral genes encoding CP or *RT* (Figure [S4](#pld347-sup-0001){ref-type="supplementary-material"}b), and in the *CUT CP* lines that displayed symptoms. In contrast, viral DNA was undetectable in symptomless *CUT CP* lines (Figure [1](#pld347-fig-0001){ref-type="fig"}b, and Figure [S4](#pld347-sup-0001){ref-type="supplementary-material"}b). The number of symptomless *CUT CP/No Cas9* control plants was similar to that of CaMV‐infected wt and *CUT GLV*, suggesting that sgRNAs complementary to invading viruses without Cas9 do not induce resistance (Figure [1](#pld347-fig-0001){ref-type="fig"}a).

During CaMV infection, 35S and 19S viral RNAs are produced in the nucleus and subsequently translocated to the cytoplasm for translation. The 35S viral RNA also serves as a template to produce progeny dsDNAs in the cytoplasm. Although a remote possibility, viral RNAs might be targeted by small interfering RNAs (siRNAs) generated from sgRNAs and if so, virus resistance could possibly be due to RNAi and not the CRISPR‐Cas9 system. To test this notion, we performed small RNA deep sequencing on mock‐inoculated or CaMV‐inoculated leaves at three DPI in wt, *CUT GLV*,*CUT CP* plants. In particular, we focused on small RNAs that are 21, 22, and 24 nucleotides (nt) in length, because they are derived from the activity of different DICER‐LIKE (DCL) proteins and are involved in RNAi (Seo, Wu, Lii, Li, & Jin, [2013](#pld347-bib-0028){ref-type="ref"}). We considered these sizes of small RNAs as siRNAs in this report. In contrast, other sizes of small RNAs are more likely to be degradation products of longer RNAs. In the absence of infection, plants expressing the *CP* sgRNA arrays accumulated three siRNAs in one *CUT CP* transgenic line, *CUT CP*‐1 (Figure [2](#pld347-fig-0002){ref-type="fig"}a, the panel of *pCUT CP*‐1 uninfected). The copy number of each siRNAs was very low (1--10 copies among 10 million small RNA reads). Arabidopsis leaf tissues that were inoculated with CaMV showed abundant siRNA production from viral RNAs at 3 days postinfection (DPI). The highest abundant siRNAs were located at the 3' end of CaMV genome (Figure [2](#pld347-fig-0002){ref-type="fig"}a). Compared to wt and *CUT GLV* plants, siRNAs mapped to the CaMV DNA sequence did not show higher abundances in *CUT CP* leaves inoculated with CaMV (Figure [2](#pld347-fig-0002){ref-type="fig"}a). Therefore, the siRNA‐mediated antiviral effect was not triggered by the introduction of multiple sgRNAs in Arabidopsis transgenic plants.

![Small RNAs generated from CaMV RNA and sgRNAs. (a) Small RNAs that are mapped to the CaMV genome. Small RNAs of different sizes are indicated by different colored dots, displaying only sizes potentially produced by Dicer (21/22/24 nt). The *X*‐axis shows small RNA abundances (RP10M) in corresponding small RNA libraries and the strand (W or C) to which they map. The *Y*‐axis indicates the position (5'‐terminal nucleotide position) of mapped small RNAs. (b) Small RNAs mapped to the six sgRNAs. The reads are from combined libraries of CaMV‐inoculated *CUT CP‐1* and *‐2* at 3 DPI. The top panel shows an IGV screenshot for the collapsed view for sgRNA1. The red box indicates the region that is enhanced in the six lower panels, as this region varies among sgRNAs because the seed region of guide RNAs is within the 5' terminal 22 to 23 nucleotides, while the remaining sequence is an invariant backbone. Gray shading at the top indicates coverage of small RNAs; red and blue colors indicate reads generated from "+" and "−" strands of the backbone. The lower six panels display small RNAs from the viral‐specific seed regions of the six sgRNAs; the gray dotted lines indicate the border of the seed region. Small RNAs were generated from the seed region of sgRNA5; for sgRNA6, of the few reads generated from the sgRNA6 seed region, the 3' portion of nearly all corresponds to the nonseed backbone, meaning that these reads have little homology to viral RNAs. Small RNA sizes are indicated by colored dots as in Panel A, at the left end of each read in the lower six panels](PLD3-2-e00047-g002){#pld347-fig-0002}

To further test whether sgRNAs produce siRNAs, we mapped siRNA reads to these six sgRNA sequences. Few siRNAs were generated from the 5'‐terminal target site‐specific regions of sgRNAs; in contrast, abundant 21‐nt siRNAs were derived from the antisense strand of a region close to the 3' end of the sgRNAs (Figure [2](#pld347-fig-0002){ref-type="fig"}b). It is likely that these siRNAs are from dsRNAs and are dependent on the activity of RNA‐dependent RNA polymerases and likely DCL4 (dicer‐like 4) due to their 21‐nt length. We performed siRNA target prediction against the CaMV RNA using sgRNA‐derived siRNAs, and these abundant siRNAs were not predicted to target the viral RNA, because of a lack of sequence complementarity. In addition, there were no siRNAs mapped to the 5' spacer region of sgRNA1‐4. We observed only three 24‐nt and one 22‐nt siRNAs derived from the 5' spacer region of the sgRNA5 and one 21‐nt siRNA mapped to that of sgRNA6 (Figure [2](#pld347-fig-0002){ref-type="fig"}b). However, the abundance of these latter siRNAs was much lower than the sum of all siRNAs targeting CaMV genome, and therefore, they seem unlikely to play a role in suppressing CMV RNAs. In summary, siRNA data confirmed that enhanced viral resistance is unlikely to be the result of siRNA‐mediated silencing of viral RNAs. However, cellular RNAi could regulate the abundance of sgRNAs by producing siRNAs concentrating at the 3' end of sgRNAs, in particular, when multiple sgRNAs are present in a single cell.

We next tested the editing events at earlier and later stages of viral infection. For the earlier stage, we harvested and extracted DNA from CaMV‐inoculated local leaves of *CUT CP* plants at three DPI. We amplified and cloned the *CP* coding sequences into a cloning vector. Among the 129 clones we tested, 56 of them had shorter *CP* fragments based on restriction enzyme digestion. Sequencing of eight randomly picked clones (of the 56) showed large deletions in the CP coding sequence, ranging from 590 base pairs (bp) to 1351 bp (Figure [3](#pld347-fig-0003){ref-type="fig"}a). The large deletions were consistent with Cas9‐mediated editing events and the expression of six sgRNAs targeting the N‐terminal 440 bp of the CP coding sequence (Figure [3](#pld347-fig-0003){ref-type="fig"}a). However, the deleted sequences, in most cases, extended beyond the 440 bp region and in several cases, beyond even the *CP* coding sequence. The 43% of clones that contained deletions is an underestimate of editing events because deletions caused by editing might have extended over the region covered by the pair of primers utilized. We cannot totally rule out the possibility that these deletions maybe due to the degradation of inoculum, which we rinsed extensively with water. For the later infection stage, we used the systemically infected leaves of two *CUT CP* symptomatic plants. Among the 13 randomly sequenced *CP* gene clones, we recovered eight clones with wt *CP* sequences, and five mutants with short deletions or insertions consistent with Cas9‐induced DNA breaks at the sgRNA target sites in *CP* (Figure [3](#pld347-fig-0003){ref-type="fig"}b). Insertions were derived from duplications events in CaMV *CP* sequence. Many of the mutant CaMV encode CP protein predicted to be nonfunctional (Table [S1](#pld347-sup-0002){ref-type="supplementary-material"}). In these cases, we always recovered wt *CP* coding sequence as well, suggesting that mutant CaMV is likely packaged in virions via wt CP *in trans*. It should be noted that we did not identify any mutants with large deletions. It is likely that the large deletion was detrimental to CaMV survival and thus, such mutants were lost during viral infection.

![The editing events in the local and systemic leaves of *CUT CP* transgenic plants infected with CaMV. (a) Large deletions identified in CaMV genome recovered from the inoculated leaves at 3 DPI. Numbers on top of the bar represent positions in the CaMV genome. Numbers below bars show positions in the *CP* ORF, which is colored as gray. The two primers used to amplify the CaMV fragment of 2115‐3761 encompassing the *CP* gene are identified as gradient bars. (b) CaMV‐induced Cas9 editing events from systemic tissues of *CUT CP* showing symptoms. Chromatographs from the sequenced CaMV *CP* gene cloned from *CUT CP* plants displaying symptoms. Blue bar, sgRNA target sequence (G5), red bar (PAM site)](PLD3-2-e00047-g003){#pld347-fig-0003}

The complete resistance of the majority of *CUT CP* plants to CaMV infection suggests that Cas9‐mediated viral targeting can be an effective strategy to control CaMV infection. Cas9‐directed virus resistance has been achieved in several classes of human viruses, including reverse transcribing viruses HIV and hepatitis B virus, as well as dsDNA viruses including human papillomavirus and Epstein--Barr virus (Price et al., [2016](#pld347-bib-0024){ref-type="ref"}). Viral resistance to several plant geminiviruses conferred by CRISPR‐Cas9 has also been reported (Ali et al., [2015](#pld347-bib-0001){ref-type="ref"}; Baltes et al., [2015](#pld347-bib-0004){ref-type="ref"}; Chaparro‐Garcia et al., [2015](#pld347-bib-0006){ref-type="ref"}; Ji et al., [2015](#pld347-bib-0014){ref-type="ref"}), indicating the broad‐range of applicability to confer resistance to viruses that viral dsDNA plays a critical role during their infections. However, virus mutants that escape CRISPR‐Cas9‐mediated resistance have been reported in several cases and in addition, it has been reported that different target sites may result in different levels of viral escape events. For instance, sgRNAs targeting the coding sequences of plant geminiviruses led to frequent viral escapes; however, no viral escape was identified with sgRNAs targeting the noncoding intergenic region, which is essential for replication (Ali, Ali, Tashkandi, Zaidi, & Mahfouz, [2016](#pld347-bib-0002){ref-type="ref"}). This is different from what has been previously reported regarding the Cas9‐mediated resistance to HIV (Wang, Pan, et al., [2016](#pld347-bib-0030){ref-type="ref"}; Wang, Zhao, Berkhout, & Das, [2016a](#pld347-bib-0031){ref-type="ref"}; Wang et al., [2016b](#pld347-bib-0032){ref-type="ref"}). Escaped HIV mutants have been generated in Cas9‐expressing cells and single sgRNAs targeting either coding sequences or noncoding long terminal repeats (LTRs). However, sgRNAs targeting highly conserved sequences, either coding or noncoding sequences, resulted in lower levels of escape mutants than those nonconserved sequences (Wang, Pan, et al., [2016](#pld347-bib-0030){ref-type="ref"}; Wang et al., [2016b](#pld347-bib-0032){ref-type="ref"}). Of note, the combinations of two single sgRNAs, especially those far from each other, substantially delayed the resistance breakdown compared to single sgRNAs. In particular, certain combinations of two sgRNAs permanently blocked HIV infection (Wang et al., [2016a](#pld347-bib-0031){ref-type="ref"}). In the present work, we generated transgenic plants expressing both Cas9 and six sgRNAs targeting CP sequences within a fragment of \~440 bp. We found large deletions within *CP* in the CaMV‐inoculated leaves as early as three DPI. These deletions extended beyond the *CP* region containing all sgRNA sequences and are not consistent with DNA repairs that are mediated by nonhomologous end‐joining. This could be due to multiple sgRNAs concentrating at a short DNA fragment, introducing unexpected deletions. It is also possible that repairing the circular CaMV genome with multiple breaks generated by multiple sgRNAs maybe different from the noncircular DNA (either as part of chromosome or as linear DNA fragment). Large deletion caused by expressing two sgRNAs has been reported during infection of geminivirus bean yellow dwarf virus. The majority of deletions occur between two sgRNAs with intact sequences flanking sgRNA‐targeted sites; however, one of six clones had an extended deletion beyond the sgRNA‐targeting sequence (Baltes et al., [2015](#pld347-bib-0004){ref-type="ref"}). Although the rate of extended deletion is lower than that in our report, this points out the possibility that multiple sgRNAs targeting circular DNA may result in unexpected deletions.

Our work also demonstrates that modified viruses are present in systemically infected leaf tissues, raising the possibility that Cas9‐mediated viral targeting has the potential to create and allow the dissemination of mutant viruses from plants even with multiple sgRNAs. The presence of duplication events suggests that Cas9 can promote recombination within viral genomes. This observation has implications for Cas9‐mediated viral immunity strategies in plants. Targeting the *CP* of CaMV likely allows the escape of mutant viruses through the acquisition of wt CP function *in trans* from coinfecting viruses. Targeting of essential cis‐acting regions of the viral genome might help to prevent the escape of modified viruses based on previous geminivirus studies (Ali et al., [2016](#pld347-bib-0002){ref-type="ref"}), in which Cas9 editing reduced viral accumulation and plant symptoms. While our current sgRNA system allows up to 14 sgRNAs in one vector (Peterson et al., [2016](#pld347-bib-0023){ref-type="ref"}), a higher order multiplex strategy based on tRNA processing has been reported (Xie, Minkenberg, & Yang, [2015](#pld347-bib-0033){ref-type="ref"}), enabling the targeting of multiple conserved cis‐ and trans‐elements at multiple sites in various species. It is possible that arrays could be designed to target conserved sites among different viral strains or be combined to target multiple strains, or different viruses, making resistance broad‐spectrum as well as durable. The use of RNA‐targeting Cas9 variants (Price, Sampson, Ratner, Grakoui, & Weiss, [2015](#pld347-bib-0025){ref-type="ref"}) may additionally allow for the targeting of RNA viruses.

When controlling viruses using the CRISPR‐Cas9 system, both Cas9 and sgRNAs are consistently expressed in the cells. Recruiting Cas9 to viral DNAs depends on the presence and abundance of sgRNAs. However, with the presence of folded dsRNA domains in sgRNAs, siRNAs can be produced to contain the foreign RNAs. Based on deep sequencing of small RNAs, we provided evidence that abundant 21‐nt siRNAs were derived from the antisense strand of a region close to the 3' end of the sgRNAs (Figure [2](#pld347-fig-0002){ref-type="fig"}b). The 3' end of sgRNAs is identical among all sgRNAs. Our data suggest that the cellular RNAi pathway could affect the abundance of sgRNAs and should be considered in the future application of the CRISPR‐Cas9 system.
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